SPP1 and stroke disorder: Increases in OPN in the CSF, and specifically in neurons, have been reported in neurodegenerative disorders including multiple sclerosis, Alzheimer’s and Parkinson’s diseases, frontotemporal dementia, and in models of brain injury and stroke.